title: Pharmacokinetics of (R,S)-Albuterol after aerosol inhalation in healthy adult volunteers.
abstract: The pharmacokinetics of inhaled (R,S)-albuterol following pulmonary absorption were studied in healthy human subjects. Ten subjects (5 females and 5 males) inhaled two puffs (180 microg) of albuterol via a metered-dose inhaler and spacer device. All subjects were nonsmoking and had normal pulmonary function. Charcoal slurries were ingested to block gastrointestinal absorption of drug. Venous samples were obtained from each subject at thirteen time points from 0 through 12 h post dose. (R,S)-Albuterol concentration in plasma was measured using a gas chromatography-mass spectrometry (GC-MS) assay. The plasma concentration-time profiles conformed to a two-compartment extravascular model with first-order absorption kinetics. The drug levels reached maximum in 12.6 +/- 2.2 (SD) minutes, which is in contrast with previous reports that maximum plasma concentrations occur within 2 to 4 h. The mean peak plasma level was 1469 +/- 410 pg/mL. The mean half-life of distribution was 17.9 +/- 8.2 min. The mean half-life of elimination was 4.4 +/- 1.5 h. Female subjects achieved peak concentration more rapidly than male subjects (10.4 vs 14.8 min, p = 0.01) and had a higher mean peak concentration (1778 vs 1159 pg/mL, p = 0.04).
authors.affiliation: Division of Pulmonary and Critical Care Medicine, , University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA. PaulaAnderson@exchange.uams.edu
authors.forename: P J
authors.initials: PJ
authors.lastname: Anderson
authors.forename: X
authors.initials: X
authors.lastname: Zhou
authors.forename: P
authors.initials: P
authors.lastname: Breen
authors.forename: L
authors.initials: L
authors.lastname: Gann
authors.forename: T W
authors.initials: TW
authors.lastname: Logsdon
authors.forename: C M
authors.initials: CM
authors.lastname: Compadre
authors.forename: F C
authors.initials: FC
authors.lastname: Hiller
mesh_terms: D000042:Absorption; D000280:Administration, Inhalation; D000318:Adrenergic beta-Agonists / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology*; D000328:Adult; D000336:Aerosols; D000420:Albuterol / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics*; D001993:Bronchodilator Agents / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology*; D005260:Female; D008401:Gas Chromatography-Mass Spectrometry; D006801:Humans; D008168:Lung / Q000378:metabolism*; D008297:Male; D013237:Stereoisomerism
chemical_list: D000318:Adrenergic beta-Agonists; D000336:Aerosols; D001993:Bronchodilator Agents; D000420:Albuterol